Diagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptoms
- 1 March 1997
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 1 (2) , 106-112
- https://doi.org/10.1016/s1091-255x(97)80097-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The role ofras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitisInternational journal of pancreatology, 1993
- Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.1993
- Serum Levels of CA 19-9 and CA 50 in Relation to Lewis Blood Cell Status in Patients with Malignant and Benign Pancreatic DiseasePancreas, 1993
- Crude Isolation of DNA from Unselected Human Pancreatic Tissue and Amplification by the Polymerase Chain Reaction ofKi-RasOncogene to Detect Point Mutations in Pancreatic CancerActa Oncologica, 1992
- Carcinoma of the PancreasAnnals of Surgery, 1985
- Monoclonal Antibodies against Gastrointestinal Tumour-Associated Antigens Isolated as MonosialogangliosidesInternational Archives of Allergy and Immunology, 1983
- LEWIS BLOOD-TYPE MAY AFFECT THE INCIDENCE OF GASTROINTESTINAL CANCERThe Lancet, 1982
- Galactosyltransferase Isoenzyme II in the Detection of Pancreatic Cancer: Comparison with Radiologic, Endoscopic, and Serologic TestsNew England Journal of Medicine, 1981
- Colorectal carcinoma antigens detected by hybridoma antibodiesSomatic Cell and Molecular Genetics, 1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958